Spironolactone for the Treatment of Melasma

NCT03953209 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Conflict with funding

Conditions

Melasma

Interventions

DRUG: Spironolactone 50Mg Tablet
DRUG: Spironolactone 100Mg Tablet
DRUG: Spironolactone 200Mg

Sponsor

Medical University of South Carolina